期刊文献+

HIV蛋白酶抑制剂利托那韦的合成工艺改进 被引量:3

Improved synthesis of HIV protease inhibitor ritonavir
原文传递
导出
摘要 目的改进HIV蛋白酶抑制剂利托那韦的合成工艺。方法以L-苯丙氨酸为原料,经三苄基保护、还原性缩合及格氏试剂偶联、α,β-不饱和酮还原、Boc保护、选择性脱苄基、缩合、脱Boc基、再次缩合得到利托那韦。结果与结论目标化合物的结构经~1H-NMR、^(13)C-NMR和MS谱确证,总收率为73.3%(以L-苯丙氨酸计),HPLC法测定纯度达99.8%。与文献报道的工艺相比,该路线操作简易、成品质量好、生产成本较低,有利于工业化生产。 The synthetic route for the preparation of HIV protease inhibitor ritonavir was improved with a series of successive steps,including the protection of L-phenylalanine by tribenzylation, reductive condensa- tion, coupled reaction by Grignard reagent, reduction reaction of α ,β-unsaturated ketone, Boc protection, and deprotection of selective benzyl, followed by condensation, Boc deprotection as well as recondensation. The structure of the obtained product was further characterizated by 1H-NMR, 13C-NMR and MS. The overall yield of the product could be achieved as high as 73.3% in this way ,together with a high purity of 99.8%, detected and confirmed by HPLC. Compared with traditional technologies, this low-cost synthetic approach for high-quality product was operated easily, which was suitable and promising for industrial production.
出处 《中国药物化学杂志》 CAS CSCD 北大核心 2018年第1期29-33,共5页 Chinese Journal of Medicinal Chemistry
基金 辽宁百千万人才工程项目(【2015】2号) 辽宁省博士启动基金项目(201501139) 沈阳市科学技术计划项目(F16-179-9-00)
关键词 利托那韦 HIV蛋白酶 抑制剂 工艺改进 tonavir HIV protease inhibitor process improvement
  • 相关文献

参考文献3

二级参考文献21

  • 1刘建建,刘新泳.HIV-1蛋白酶抑制剂分子设计策略研究进展[J].中国新药杂志,2006,15(4):247-254. 被引量:4
  • 2Sham HL, Norbeck DW, Chen XQ, et al. Retroviral protease inhibiting compounds: US, 5914332 [P]. 1999-06-22. (CA 1999, 131: 59143)
  • 3靳立人,许志杰,蒋洪平.一种合成利托那韦的方法:中国,1247554[P].2004.12.15
  • 4靳立人,许志杰,蒋洪平.一种合成利托那韦的方法:WO,98/28366[P].1998.07.02.(CA1998,129:123301)
  • 5Haight AR, Stuk TL, Menzia JA. Process for the preparation of substituted keto enamines: WO, 9854122 [P]. 1998-12-03. (CA 1999, 130: 38194)
  • 6Haight AR, Goodmonson O J, Parekh SI, et al. Process for the preparation of a substituted 2,5-diamino-3-hydroxyhexane: WO, 9604232 [P]. 1996-02-15. (CA 1996, 125: 33306)
  • 7Kempf DJ, Norbeck DW. Retroviral protease inhibiting compounds: US, 5541206 [P]. 1996-06-30
  • 8Kempf DJ, Norbeck DW. Retroviral protease inhibiting compounds:EP, 402646 [P]. 1990-12-19. (CA 1991, 115: 50304)
  • 9Stuk TL, Allen MS, Haight AR, et al. Process for the preparation of a substituted 2,5-diamino-3-hydroxyhexane: US, 5491253 [P]. 1996-02-13. (CA 1996, 124: 342844)
  • 10Josbi A, Vron J/J, Unge J, et al. Design and synthesis of P1 P3 macrocyelic tertiary-alcohol-comprising HIV-1 protease inhlbi- torsi J]. J Med Chem,2013,56(22) : 8999 -9007.

共引文献9

同被引文献41

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部